NYSE:PFE (Pfizer Inc.)

About PFE

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.

Pfizer Inc. (NYSE: PFE) Latest News

Investing Articles

Who Can Pfizer Inc. Afford?

Are Bristol-Myers Squibb Co (NYSE: BMY) or Shire PLC (LON:SHP) on Pfizer Inc. (NYSE:PFE)'s shopping list?

Read more »

Investing Articles

AstraZeneca plc: Time To Cash In?

There are several reasons why Astra (LON:AZN) investors may want to cash in now, argues Alessandro Pasetti

Read more »

Company Comment

Lessons From The Great Investors… On Coca-Cola And AstraZeneca plc

AstraZeneca plc (LON: AZN) and Coca-Cola are the quintessential investments of two of the all-time greats.

Read more »

Company Comment

What You Need To Know About AstraZeneca plc Rejecting Pfizer’s Final Offer

AstraZeneca plc (LON: AZN) will live on as a standalone entity with ambitious revenue targets and a buzzing drugs pipeline.

Read more »

Investing Articles

What Could Pfizer-AstraZeneca Be Like?

What might be the positives from this potential takeover?

Read more »

Company Comment

Would A Combined AstraZeneca plc/Pfizer Inc. Be Worth Owning?

AstraZeneca plc's (LON: AZN) strengths as a separate entity won't be best harnessed by Pfizer Inc. (NYSE:PFE)

Read more »

Investing Articles

Is The Pfizer Takeover Offer for AstraZeneca plc ‘Un-American’?

Pfizer Inc. (NYSE:PFE) has AstraZeneca plc (LON:AZN) firmly in its sights as a home for the $69bn of earnings it…

Read more »